Molina Healthcare Reports Second Quarter 2024 Financial Results

Reaffirms Full Year 2024 Earnings Guidance

Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter 2024 GAAP earnings per diluted share of $5.17 and adjusted earnings per diluted share of $5.86. Financial results are summarized below:

Three months ended

Six months ended

June 30,

2024

2023

2024

2023

(In millions, except per-share results)

Premium Revenue

9,446

8,042

18,950

15,927

Total Revenue

9,880

8,327

19,811

16,476

GAAP:

Net Income

301

309

602

630

EPS – Diluted

5.17

5.35

10.33

10.87

Medical Care Ratio (MCR)

88.6

87.5

88.6

87.3

G&A Ratio

7.0

7.4

7.1

7.3

After-tax Margin

3.0

3.7

3.0

3.8

Adjusted:

Net Income

341

327

675

664

EPS – Diluted

5.86

5.65

11.59

11.45

G&A Ratio

6.9

7.4

7.0

7.3

After-tax Margin

3.5

3.9

3.4

4.0

See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Quarter Highlights

As of June 30, 2024, the Company served approximately 5.6 million members, an increase of 8% compared to June 30, 2023.
Premium revenue was approximately $9.4 billion for the second quarter of 2024, an increase of 17% year over year.
GAAP net income was $5.17 per diluted share for the second quarter of 2024, a decrease of 3% year over year.
Adjusted net income was $5.86 per diluted share for the second quarter of 2024, an increase of 4% year over year.
The Company reaffirmed its full year 2024 guidance with expected premium revenue of approximately $38 billion and adjusted earnings of at least $23.50 per diluted share.

“We are pleased with our performance in the quarter as our flagship Medicaid business continues to perform well along with strong contributions from both our Medicare and Marketplace businesses,” said Joseph Zubretsky, President and Chief Executive Officer. “We have successfully navigated the unprecedented redetermination process, and these highly attractive businesses provide the foundation for near and long-term sustainable profitable growth.”

Premium Revenue

Premium revenue was approximately $9.4 billion for the second quarter of 2024, an increase of 17% year over year. The higher premium revenue reflects new contract wins, acquisitions, and growth in our current footprint, partially offset by the impact of Medicaid redeterminations.

Net Income

GAAP net income for the second quarter of 2024 was $5.17 per diluted share, a decrease of 3% year over year. Adjusted net income for the second quarter of 2024 was $5.86 per diluted share, an increase of 4% year over year.

Medical Care Ratio (MCR)

The consolidated MCR for the second quarter of 2024 was 88.6% and reflects continued focus on managing medical costs.
The Medicaid MCR for the second quarter of 2024 was 90.8%. Within that result, approximately 70 basis points were due to a one-time, retroactive premium adjustment related to the prior year. “New store” Medicaid plans increased the reported MCR by approximately 80 basis points. Excluding the one-time item and new stores, the Medicaid MCR was approximately 89.3% and modestly higher than the Company’s long-term expectations due to redetermination-related acuity shifts.
The Medicare MCR for the second quarter of 2024 was 84.9%, better than the Company’s expectations, and reflects favorable risk adjustment results, and benefit adjustments implemented for 2024.
The Marketplace MCR for the second quarter of 2024 was 71.6%, better than the Company’s expectations, and reflects the Company’s favorable risk adjustment results.

General and Administrative Expense Ratio

The G&A ratio and the adjusted G&A ratio for the second quarter of 2024 were 7.0% and 6.9%, respectively.

Balance Sheet

Cash and investments at the parent company were $235 million as of June 30, 2024 compared to $742 million as of December 31, 2023.

Days in claims payable at June 30, 2024 was 50.

Cash Flow

Operating cash flow for the six months ended June 30, 2024 was a use of $5 million, compared to $1,403 million for the six months ended June 30, 2023. The decrease in cash flow for the period year-over-year was driven mainly by the net impact of timing differences in government receivables and payables, including Medicare and Medicaid prepayments, risk corridor settlement activity, and timing differences in receipts and payments of provider payables.

2024 Guidance

Premium revenue for the full year is expected to be approximately $38 billion, an increase of approximately 17% from the full year 2023.

The Company reaffirms its full year adjusted earnings per diluted share in 2024 to be at least $23.50, representing approximately 13% growth over the full year 2023. The Medicaid pressure experienced in the second quarter of 2024 is expected to be offset by higher net investment income and the extension of Virginia and Florida contracts in the second half of the year. The Company’s known rate adjustments in the second half of the year are expected to largely offset higher expected trend in the second half of the year.

Conference Call

Management will host a conference call and webcast to discuss Molina Healthcare’s second quarter results at 8:00 a.m. Eastern Time on Thursday, July 25, 2024. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 8508329. A telephonic replay of the conference call will be available through Thursday, August 1, 2024, by dialing (877) 344-7529 and entering confirmation number 5266367. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

This earnings release and the Company’s accompanying oral remarks contain forward-looking statements. The Company intends such forward-looking statements to be covered under the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements provide current expectations of future events based on certain assumptions, and all statements other than statements of historical fact contained in this earnings release and the Company’s accompanying oral remarks may be forward-looking statements. In some cases, you can identify forward-looking statements by words such as “guidance,” “future,” “anticipates,” “believes,” “embedded,” “estimates,” “expects,” “growth,” “intends,” “plans,” “predicts,” “projects,” “will,” “would,” “could,” “can,” “may,” or the negative of these terms or other similar expressions. Forward-looking statements contained in this earnings release include, but are not limited to, statements regarding our business and financial performance, 2024 guidance and long-term targets, expected headwinds, normal and off-cycle Medicaid rate adjustments, and management’s plans and objectives for future operations and business strategy.

Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2023, which is on file with the U.S. Securities and Exchange Commission (the “SEC”), and in the Company’s other filings with the SEC, including its Quarterly Report on Form 10-Q for the period ended June 30, 2024, to be filed with the SEC.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of July 24, 2024, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.

MOLINA HEALTHCARE, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

Three Months Ended

Six Months Ended

June 30,

2024

2023

2024

2023

(In millions, except per-share amounts)

Revenue:

Premium revenue

9,446

8,042

18,950

15,927

Premium tax revenue

298

169

595

341

Investment income

115

223

168

Other revenue

Total revenue

9,880

8,327

19,811

16,476

Operating expenses:

Medical care costs

8,368

7,038

16,782

13,909

General and administrative expenses

691

618

1,402

1,209

Premium tax expenses

298

169

595

341

Depreciation and amortization

Other

Total operating expenses

9,446

7,884

18,951

15,578

Operating income

434

443

860

898

Interest expense

Income before income tax expense

406

416

805

843

Income tax expense

105

107

203

213

Net income

301

309

602

630

Net income per share – Diluted

5.17

5.35

10.33

10.87

Diluted weighted average shares outstanding

58.2

57.9

58.3

58.0

MOLINA HEALTHCARE, INC.

CONSOLIDATED BALANCE SHEETS

June 30,

December 31,

2024

2023

Unaudited

(Dollars in millions,

except per-share amounts)

ASSETS

Current assets:

Cash and cash equivalents

4,354

4,848

Investments

4,347

4,259

Receivables

3,231

3,104

Prepaid expenses and other current assets

399

331

Total current assets

12,331

12,542

Property, equipment, and capitalized software, net

305

270

Goodwill and intangible assets, net

1,913

1,449

Restricted investments

268

261

Deferred income taxes, net

232

227

Other assets

136

143

Total assets

15,185

14,892

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Medical claims and benefits payable

4,577

4,204

Amounts due government agencies

2,273

2,294

Accounts payable, accrued liabilities and other

973

1,252

Deferred revenue

418

Total current liabilities

7,836

8,168

Long-term debt

2,181

2,180

Finance lease liabilities

203

205

Other long-term liabilities

122

124

Total liabilities

10,342

10,677

Stockholders’ equity:

Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at June 30, 2024, and 58 million at December 31, 2023

—

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

—

Additional paid-in capital

439

410

Accumulated other comprehensive loss

(85

)

(82

)

Retained earnings

4,489

3,887

Total stockholders’ equity

4,843

4,215

Total liabilities and stockholders’ equity

15,185

14,892

MOLINA HEALTHCARE, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

Six Months Ended

June 30,

2024

2023

(In millions)

Operating activities:

Net income

602

630

Adjustments to reconcile net income to net cash (used in) provided by operating activities:

Depreciation and amortization

Deferred income taxes

)

Share-based compensation

Other, net

Changes in operating assets and liabilities:

Receivables

)

(83

)

Prepaid expenses and other current assets

Medical claims and benefits payable

(48

)

149

Amounts due government agencies

(43

)

510

Accounts payable, accrued liabilities and other

(307

)

(208

)

Deferred revenue

(405

)

Income taxes

202

Net cash (used in) provided by operating activities

)

1,403

Investing activities:

Purchases of investments

(594

)

(924

)

Proceeds from sales and maturities of investments

506

546

Net cash paid in business combinations

(295

)

—

Purchases of property, equipment, and capitalized software

(54

)

(63

)

Other, net

Net cash used in investing activities

(435

)

(439

)

Financing activities:

Common stock withheld to settle employee tax obligations

(56

)

(59

)

Other, net

Net cash used in financing activities

(50

)

(55

)

Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents

(490

)

909

Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period

4,908

4,048

Cash, cash equivalents, and restricted cash and cash equivalents at end of period

4,418

4,957

MOLINA HEALTHCARE, INC.

UNAUDITED SEGMENT DATA

(Dollars in millions)

June 30,

December 31,

June 30,

2024

2023

Ending Membership by Segment:

Medicaid

4,942,000

4,542,000

4,741,000

Medicare

251,000

172,000

166,000

Marketplace

386,000

281,000

269,000

Total

5,579,000

4,995,000

5,176,000

Three Months Ended June 30,

2024

2023

Premium Revenue

Medical Margin

MCR (1)

Premium Revenue

Medical Margin

MCR (1)

Medicaid

7,378

683

90.8

6,485

756

88.3

Medicare

1,441

217

84.9

1,044

113

89.2

Marketplace

627

178

71.6

513

135

73.7

Consolidated

9,446

1,078

88.6

8,042

1,004

87.5

Six Months Ended June 30,

2024

2023

Premium Revenue

Medical Margin

MCR (1)

Premium Revenue

Medical Margin

MCR (1)

Medicaid

14,870

1,458

90.2

12,834

1,490

88.4

Medicare

2,883

380

86.8

2,090

239

88.6

Marketplace

1,197

330

72.4

1,003

289

71.2

Consolidated

18,950

2,168

88.6

15,927

2,018

87.3

_____________

(1)

The MCR represents medical costs as a percentage of premium revenue.

MOLINA HEALTHCARE, INC.

CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE

(Dollars in millions)

The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

Six Months Ended

June 30,

2024

2023

Unaudited

Medical claims and benefits payable, beginning balance

4,204

3,528

Components of medical care costs related to:

Current year

17,301

14,180

Prior year

(519

)

(271

)

Total medical care costs

16,782

13,909

Payments for medical care costs related to:

Current year

13,429

11,166

Prior year

3,161

2,650

Total paid

16,590

13,816

Acquired balances, net of post-acquisition adjustments

421

—

Change in non-risk and other payables

(240

)

Medical claims and benefits payable, ending balance

4,577

3,677

Days in Claims Payable (1)

__________________

(1)

The Company calculates Days in Claims Payable using claims incurred but not paid, or IBNP, and other fee-for-service payables included in medical claims and benefits payable, and quarterly fee-for-service related costs included in medical care costs within the Company’s consolidated financial statements.

MOLINA HEALTHCARE, INC.

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES

(In millions, except per diluted share amounts)

The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.

Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.

Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.

Adjusted net income represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.

Adjusted net income per diluted share represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

Adjusted after-tax margin represents adjusted net income, divided by total revenue.

Three Months Ended June 30,

Six Months Ended June 30,

2024

2023

2024

2023

Amount

Per Diluted Share

Amount

Per Diluted Share

Amount

Per Diluted Share

Amount

Per Diluted Share

GAAP Net income

301

5.17

309

5.35

602

10.33

630

10.87

Adjustments:

Amortization of intangible assets

0.36

0.71

0.73

Acquisition-related expenses (1)

0.31

0.03

0.60

0.03

Other (2)

0.24

—

0.35

—

Subtotal, adjustments

0.91

0.39

1.66

0.76

Income tax effect

(13

)

(0.22

)

(0.09

)

(23

)

(0.40

)

(11

)

(0.18

)

Adjustments, net of tax

0.69

0.30

1.26

0.58

Adjusted net income

341

5.86

327

5.65

675

11.59

664

11.45

__________________

(1)

Reflects non-recurring costs associated with acquisitions, including various transaction and certain integration costs.

(2)

The six months ended June 30, 2024 includes non-recurring litigation costs and one-time termination benefits.

MOLINA HEALTHCARE, INC.

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED)

2024 GUIDANCE

Amount

Per Diluted Share (2)

GAAP Net income

1,256

21.62

Adjustments:

Amortization of intangible assets

1.42

Acquisition-related expenses

0.75

Other

0.35

Subtotal, adjustments

147

2.52

Income tax effect (1)

(38

)

(0.64

)

Adjustments, net of tax

109

1.88

Adjusted net income

1,365

23.50

__________________

(1)

Income tax effect calculated at the statutory tax rate of approximately 23.9%.

(2)

Computations assume approximately 58.1 million diluted weighted average shares outstanding.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240724464177/en/

Investor Contact: Jeffrey Geyer, Jeffrey.Geyer@molinahealthcare.com, 305-317-3012 Media Contact: Caroline Zubieta, Caroline.Zubieta@molinahealthcare.com, 562-951-1588

Molina Healthcare (NYSE:MOH)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025